What is Aptiv's operating income?

Aptiv's total operating income in 2025 was $1.18 billion, based on the following breakdown: Total Gross Profit: $3.90 billion Total Operating Expenses: $2.71 billion

Aptiv (APTV) Financials

$49.53 +0.36 (+0.72%)

Closing price 08/14/2026 03:59 PM Eastern

Extended Trading

$49.58 +0.05 (+0.11%)

As of 08/14/2026 07:43 PM Eastern

Compare

Annual Income Statements for Aptiv

This table shows Aptiv's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	1,450	1,257	1,355	1,067	990	1,769	527	531	2,909	1,787	165
Consolidated Net Income / (Loss)	1,535	1,326	1,428	1,107	1,009	1,822	609	590	2,966	1,810	181
Net Income / (Loss) Continuing Operations	852	868	1,063	1,107	1,009	1,822	609	590	2,966	1,810	181
Total Pre-Tax Income	997	1,000	1,255	1,334	1,126	1,954	910	990	1,337	2,151	919
Total Operating Income	1,235	1,539	1,416	1,473	1,276	2,118	1,189	1,263	1,559	1,842	1,184
Total Gross Profit	2,173	2,747	2,614	2,729	2,646	1,940	2,436	2,635	3,439	3,711	3,898
Total Revenue	10,864	12,274	12,884	14,435	14,357	13,066	15,618	17,489	20,051	19,713	20,398
Operating Revenue	10,864	12,274	12,884	14,435	14,357	13,066	15,618	17,489	20,051	19,713	20,398
Total Cost of Revenue	8,691	9,527	10,270	11,706	11,711	11,126	13,182	14,854	16,612	16,002	16,500
Operating Cost of Revenue	8,691	9,527	10,270	11,706	11,711	11,126	13,182	14,854	16,612	16,002	16,500
Total Operating Expenses	938	1,208	1,198	1,256	1,370	-178	1,247	1,372	1,880	1,869	2,714
Selling, General & Admin Expense	803	924	952	993	1,076	976	1,075	1,138	1,436	1,465	1,673
Amortization Expense	70	117	117	154	146	144	148	149	233	211	208
Impairment Charge	-	-	-	-	-	-	-	-	0.00	0.00	648
Restructuring Charge	65	167	129	109	148	136	24	85	211	193	185
Total Other Income / (Expense), net	-238	-539	-161	-139	-150	-164	-279	-273	-222	309	-265
Interest Expense	124	155	140	141	164	164	150	219	285	337	361
Interest & Investment Income	-	-	-	0.00	0.00	-	-	-	0.00	605	46
Other Income / (Expense), net	-114	-384	-21	2.00	14	0.00	-129	-54	63	41	50
Income Tax Expense	161	167	223	250	132	49	101	121	-1,928	223	700
Other Gains / (Losses), net	16	35	31	23	15	-83	-200	-279	-299	-118	-38
Preferred Stock Dividends Declared	-	-	-	0.00	0.00	35	63	63	29	0.00	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	85	69	73	40	19	18	19	-4.00	28	23	16
Basic Earnings per Share	$5.08	$4.60	$5.07	$4.04	$3.85	$6.72	$1.95	$1.96	$10.50	$6.97	$0.75
Weighted Average Basic Shares Outstanding	285.20M	273.02M	267.16M	264.41M	256.81M	263.43M	270.46M	270.90M	276.92M	256.38M	220M
Diluted Earnings per Share	$5.06	$4.59	$5.06	$4.02	$3.85	$6.66	$1.94	$1.96	$10.39	$6.96	$0.75
Weighted Average Diluted Shares Outstanding	286.64M	273.70M	268.03M	265.22M	257.39M	270.70M	271.22M	271.18M	282.88M	256.66M	220.75M
Weighted Average Basic & Diluted Shares Outstanding	285.40M	273.30M	267.30M	264.10M	255.29M	270.03M	270.51M	270.95M	279.04M	229.45M	212.75M

This table shows Aptiv's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q2 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2026	6/30/2025	9/30/2025	12/31/2025	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	1,629	905	218	938	363	268	189	260	-355	138	248
Consolidated Net Income / (Loss)	1,637	919	224	943	368	275	191	397	-352	147	247
Net Income / (Loss) Continuing Operations	1,637	919	224	943	368	275	191	133	-352	147	-50
Total Pre-Tax Income	397	311	369	1,028	407	347	285	294	-243	354	663
Total Operating Income	446	355	419	441	503	479	378	325	-175	425	367
Total Gross Profit	893	922	878	968	903	962	920	731	1,018	963	775
Total Revenue	5,114	4,919	4,901	5,051	4,854	4,907	5,086	3,199	5,212	5,153	3,274
Operating Revenue	5,114	4,919	4,901	5,051	4,854	4,907	5,086	3,199	5,212	5,153	3,274
Total Cost of Revenue	4,221	3,997	4,023	4,083	3,951	3,945	4,166	2,468	4,194	4,190	2,499
Operating Cost of Revenue	4,221	3,997	4,023	4,083	3,951	3,945	4,166	2,468	4,194	4,190	2,499
Total Operating Expenses	447	567	459	527	400	483	542	406	1,193	538	408
Selling, General & Admin Expense	360	381	366	405	331	363	427	327	433	450	332
Amortization Expense	59	56	54	52	53	52	53	52	52	52	52
Restructuring Charge	28	130	39	70	16	68	62	27	60	36	24
Total Other Income / (Expense), net	-49	-44	-50	587	-96	-216	-93	-31	-68	-70	-1.00
Interest Expense	75	71	65	64	101	107	89	92	90	87	62
Interest & Investment Income	-	-	-	641	0.00	-	0.00	46	0.00	1.00	3.00
Other Income / (Expense), net	26	27	15	10	5.00	11	-4.00	15	22	16	58
Income Tax Expense	-1,312	-680	76	51	32	64	81	16	103	196	52
Other Gains / (Losses), net	-72	-72	-69	-34	-7.00	-	-13	-14	-6.00	-11	-17
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	-	-	-	-	-	-50
Net Income / (Loss) Attributable to Noncontrolling Interest	8.00	14	6.00	5.00	5.00	7.00	2.00	4.00	3.00	9.00	-1.00
Basic Earnings per Share	$5.76	$3.36	$0.79	$3.47	$1.48	$1.23	$0.89	$1.80	($1.63)	$0.63	$1.17
Weighted Average Basic Shares Outstanding	282.84M	276.92M	275.19M	270.19M	245.48M	256.38M	212.91M	217.73M	217.41M	220M	211.56M
Diluted Earnings per Share	$5.76	$3.25	$0.79	$3.47	$1.48	$1.22	$0.88	$1.80	($1.63)	$0.63	$1.17
Weighted Average Diluted Shares Outstanding	283.01M	282.88M	275.31M	270.43M	245.78M	256.66M	213.80M	218.11M	217.41M	220.75M	212.10M
Weighted Average Basic & Diluted Shares Outstanding	282.86M	279.04M	272.06M	265.76M	235.04M	229.45M	211.62M	217.76M	216.08M	212.75M	207.63M

This table details how cash moves in and out of Aptiv's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-325	259	758	-1,029	-139	2,424	286	-1,584	85	-66	280
Net Cash From Operating Activities	1,703	1,941	1,468	1,628	1,624	1,413	1,222	1,263	1,896	2,446	2,185
Net Cash From Continuing Operating Activities	1,140	1,494	1,106	1,640	1,624	1,413	1,222	1,269	1,896	2,446	2,185
Net Income / (Loss) Continuing Operations	852	868	1,063	1,107	1,009	1,822	609	590	2,966	1,810	181
Consolidated Net Income / (Loss)	1,535	1,326	1,428	1,107	1,009	1,822	609	590	2,966	1,810	181
Depreciation Expense	274	372	429	522	571	620	625	613	679	753	783
Amortization Expense	81	126	124	161	152	153	156	164	242	223	217
Non-Cash Adjustments To Reconcile Net Income	112	36	54	6.00	100	-1,285	375	449	516	-367	803
Changes in Operating Assets and Liabilities, net	-179	92	-564	-156	-208	103	-543	-547	-2,507	27	201
Net Cash From Investing Activities	-1,699	-578	-1,252	-2,048	-1,111	-626	-729	-5,182	-1,002	-507	-498
Net Cash From Continuing Investing Activities	-1,429	-412	-1,093	-2,048	-1,111	-626	-729	-5,182	-1,002	-507	-502
Purchase of Property, Plant & Equipment	-503	-657	-698	-846	-781	-584	-611	-844	-906	-830	-656
Acquisitions	-1,657	-18	-374	-1,213	-344	-51	-132	-4,352	-89	-121	-42
Purchase of Investments	0.00	-1.00	-28	-2.00	0.00	-1.00	-17	7.00	6.00	-750	4.00
Sale of Property, Plant & Equipment	-	-	-	-	14	10	9.00	4.00	4.00	6.00	16
Divestitures	724	245	-	-	-	-	0.00	0.00	-17	448	164
Sale and/or Maturity of Investments	7.00	19	7.00	13	0.00	0.00	22	3.00	0.00	740	12
Net Cash From Financing Activities	-284	-1,081	456	-555	-649	1,613	-191	2,359	-807	-1,965	-1,442
Net Cash From Continuing Financing Activities	-284	-1,081	458	-555	-649	1,613	-191	2,337	-807	-1,965	-1,442
Repayment of Debt	-760	-896	-15	-13	-599	-429	-1,509	-27	-332	-3,836	-1,013
Repurchase of Common Equity	-1,159	-634	-383	-499	-420	-57	0.00	0.00	-398	-4,104	-397
Payment of Dividends	-349	-359	-348	-263	-237	-98	-63	-72	-34	0.00	-6.00
Issuance of Debt	2,043	852	796	268	641	0.00	1,450	2,472	0.00	6,001	0.00
Other Financing Activities, net	-59	-44	408	-48	-34	-33	-69	-36	-43	-26	-26
Effect of Exchange Rate Changes	-45	-23	-	-	-	24	-16	-24	-2.00	-	35

This table details how cash moves in and out of Aptiv's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Change in Cash & Equivalents	185	506	-168	-699	468	-355	520	-473	348	194	211
Net Cash From Operating Activities	535	746	624	244	643	499	1,060	273	510	584	818
Net Cash From Continuing Operating Activities	535	746	624	244	643	499	1,062	273	510	584	818
Net Income / (Loss) Continuing Operations	246	1,637	919	224	943	368	275	-11	397	-352	147
Consolidated Net Income / (Loss)	246	1,637	919	224	943	368	275	-11	397	-352	147
Depreciation Expense	165	167	190	176	196	188	193	191	197	197	198
Amortization Expense	62	61	58	56	54	58	60	53	56	54	54
Non-Cash Adjustments To Reconcile Net Income	122	131	182	73	-570	28	65	33	36	723	11
Changes in Operating Assets and Liabilities, net	-60	-1,250	-725	-285	20	-143	469	7.00	-176	-38	408
Net Cash From Investing Activities	-281	-205	-207	-305	-524	-255	577	-203	-9.00	-133	-153
Net Cash From Continuing Investing Activities	-281	-205	-207	-305	-524	-255	577	-203	-9.00	-133	-157
Purchase of Property, Plant & Equipment	-222	-212	-203	-265	-226	-173	-166	-197	-149	-143	-167
Sale of Property, Plant & Equipment	-	-	1.00	0.00	-	1.00	3.00	1.00	1.00	-	14
Divestitures	-	-	-	-	-	-	-	0.00	-	-	-4.00
Net Cash From Financing Activities	-59	-20	-606	-626	362	-624	-1,077	-553	-179	-253	-457
Net Cash From Continuing Financing Activities	-59	-20	-606	-626	362	-624	-1,074	-553	-179	-253	-457
Repayment of Debt	-2.00	-20	-302	-6.00	-5.00	-2,153	-1,074	-534	-179	-147	-153
Repurchase of Common Equity	-30	-	-300	-600	-430	-3,074	-	0.00	-	-96	-301
Other Financing Activities, net	-11	-	-2.00	-20	-1.00	-2.00	-	-19	-	-4.00	-3.00
Effect of Exchange Rate Changes	-	-	-	-12	-	-	-40	10	26	-4.00	3.00

This table presents Aptiv's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	11,973	12,292	12,169	12,480	13,459	17,522	18,007	21,884	24,427	23,458	23,413
Total Current Assets	5,121	5,419	5,641	4,777	5,319	7,465	8,436	7,784	8,247	7,826	8,745
Cash & Equivalents	535	737	1,596	567	412	2,821	3,139	1,531	1,640	1,573	1,575
Restricted Cash	1.00	1.00	1.00	1.00	16	32	-	-	0.00	1.00	3.00
Accounts Receivable	2,750	2,130	2,440	2,487	2,569	2,812	2,784	3,433	3,546	3,261	1,910
Inventories, net	1,181	859	1,083	1,277	1,286	1,297	2,014	2,340	2,365	2,320	1,789
Other Current Assets	431	302	521	445	504	503	499	480	696	671	627
Other Current Nonoperating Assets	223	1,390	-	0.00	532	-	-	-	-	-	2,841
Plant, Property, & Equipment, net	3,377	2,325	2,804	3,179	3,309	3,301	3,294	3,495	3,785	3,698	2,872
Total Noncurrent Assets	3,475	4,548	3,724	4,524	4,831	6,756	6,277	10,605	12,395	11,934	11,796
Long-Term Investments	94	67	91	99	106	2,011	1,797	1,723	1,443	1,433	1,288
Goodwill	1,539	1,502	1,944	2,524	2,407	2,580	2,511	5,106	5,151	5,024	4,008
Intangible Assets	1,383	1,148	1,219	1,380	1,186	1,091	964	2,585	2,399	2,140	1,997
Other Noncurrent Operating Assets	459	280	470	521	1,132	1,074	1,005	1,191	3,402	3,337	2,147
Other Noncurrent Nonoperating Assets	-	1,551	-	-	-	-	-	-	-	-	2,356
Total Liabilities & Shareholders' Equity	11,973	12,292	12,169	12,480	13,459	17,522	18,007	21,884	24,427	23,458	23,413
Total Liabilities	9,240	9,529	8,652	8,810	9,448	9,422	9,446	12,790	12,583	14,373	13,914
Total Current Liabilities	3,927	4,148	3,540	3,694	4,054	4,046	4,207	4,865	4,808	5,131	5,037
Short-Term Debt	52	10	17	306	393	90	8.00	31	9.00	509	23
Accounts Payable	2,541	1,820	2,227	2,334	2,463	2,571	2,953	3,150	3,151	2,870	1,623
Accrued Expenses	1,204	1,242	1,296	1,054	1,155	1,385	1,246	1,684	1,648	1,752	1,191
Other Current Nonoperating Liabilities	130	1,076	-	0.00	43	-	-	-	-	-	2,200
Total Noncurrent Liabilities	5,313	5,381	5,112	5,116	5,394	5,376	5,239	7,925	7,775	9,242	8,877
Long-Term Debt	3,956	3,953	4,132	4,038	3,971	4,011	4,059	6,460	6,204	7,843	7,467
Capital Lease Obligations	-	-	-	0.00	-	300	304	361	453	412	270
Noncurrent Employee Benefit Liabilities	854	439	454	445	483	525	440	354	417	374	212
Other Noncurrent Operating Liabilities	503	371	526	633	940	540	436	750	701	613	479
Other Noncurrent Nonoperating Liabilities	-	618	-	-	-	-	-	-	-	-	449
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	-	-	-	-	-	0.00	96	99	92	102
Total Equity & Noncontrolling Interests	2,733	2,763	3,517	3,670	4,011	8,100	8,561	8,998	11,745	8,993	9,397
Total Preferred & Common Equity	2,250	2,401	3,299	3,459	3,819	7,905	8,347	8,809	11,548	8,796	9,207
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,250	2,401	3,299	3,459	3,819	7,905	8,347	8,809	11,548	8,796	9,207
Common Stock	1,656	1,636	1,652	1,642	1,648	3,900	3,942	3,992	4,031	2,968	3,621
Retained Earnings	1,627	1,980	2,118	2,511	2,890	4,550	5,077	5,608	8,162	7,002	6,227
Accumulated Other Comprehensive Income / (Loss)	-1,033	-1,215	-471	-694	-719	-545	-672	-791	-645	-1,174	-641
Noncontrolling Interest	483	362	218	211	192	195	214	189	197	197	190

This table presents Aptiv's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q2 2026
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2026	6/30/2025	9/30/2025	6/30/2026
Total Assets	22,098	23,711	24,427	23,644	24,751	24,766	23,458	25,203	23,942	23,497	17,996
Total Current Assets	8,072	8,490	8,247	7,691	8,829	8,688	7,826	10,720	8,373	8,760	6,003
Cash & Equivalents	1,302	1,808	1,640	941	1,409	1,054	1,573	3,173	1,448	1,640	761
Restricted Cash	-	-	0.00	-	-	-	1.00	4.00	1.00	3.00	4.00
Accounts Receivable	3,729	3,647	3,546	3,652	3,592	3,653	3,261	3,798	3,717	3,713	2,434
Inventories, net	2,380	2,432	2,365	2,371	2,370	2,550	2,320	2,746	2,475	2,597	2,038
Other Current Assets	661	603	696	727	710	640	671	999	732	807	766
Other Current Nonoperating Assets	-	-	-	-	-	-	-	-	-	-	0.00
Plant, Property, & Equipment, net	3,592	3,579	3,785	3,764	3,731	3,797	3,698	3,685	3,754	3,720	2,756
Total Noncurrent Assets	10,434	11,642	12,395	12,189	12,191	12,281	11,934	10,798	11,815	11,017	9,237
Long-Term Investments	1,581	1,498	1,443	1,363	1,506	1,503	1,433	1,418	1,311	1,303	1,255
Goodwill	5,140	5,073	5,151	5,110	5,078	5,170	5,024	4,548	5,248	4,593	3,937
Intangible Assets	2,487	2,423	2,399	2,326	2,263	2,235	2,140	1,940	2,105	2,055	1,875
Other Noncurrent Operating Assets	1,226	2,648	3,402	3,390	3,344	3,373	3,337	2,892	3,151	3,066	2,170
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	-	-	-	0.00
Total Liabilities & Shareholders' Equity	22,098	23,711	24,427	23,644	24,751	24,766	23,458	25,203	23,942	23,497	17,996
Total Liabilities	12,576	12,638	12,583	12,225	12,981	15,568	14,373	15,681	13,967	13,933	9,243
Total Current Liabilities	4,589	4,696	4,808	5,956	5,908	5,804	5,131	5,069	4,751	4,885	2,975
Short-Term Debt	37	43	9.00	1,487	1,475	1,257	509	102	32	17	23
Accounts Payable	3,028	3,056	3,151	2,893	2,915	2,989	2,870	3,204	3,039	3,130	1,910
Accrued Expenses	1,524	1,597	1,648	1,576	1,518	1,558	1,752	1,763	1,680	1,738	1,042
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	-	-	-	0.00
Total Noncurrent Liabilities	7,987	7,942	7,775	6,269	7,073	9,764	9,242	10,612	9,216	9,048	6,268
Long-Term Debt	6,476	6,419	6,204	4,721	5,504	8,283	7,843	9,248	7,758	7,613	5,331
Capital Lease Obligations	379	419	453	442	437	421	412	394	422	404	241
Noncurrent Employee Benefit Liabilities	380	372	417	418	407	413	374	416	426	432	212
Other Noncurrent Operating Liabilities	752	732	701	688	725	647	613	554	610	599	484
Other Noncurrent Nonoperating Liabilities	-	-	-	-	-	-	-	-	-	-	0.00
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	97	93	99	97	95	99	92	99	103	102	0.00
Total Equity & Noncontrolling Interests	9,425	10,980	11,745	11,322	11,675	9,099	8,993	9,423	9,872	9,462	8,753
Total Preferred & Common Equity	9,232	10,778	11,548	11,120	11,467	8,882	8,796	9,233	9,690	9,282	8,753
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	9,232	10,778	11,548	11,120	11,467	8,882	8,796	9,233	9,690	9,282	8,753
Common Stock	4,004	4,035	4,031	3,971	3,950	2,942	2,968	3,601	3,607	3,634	3,615
Retained Earnings	5,893	7,522	8,162	7,847	8,401	6,734	7,002	6,351	6,797	6,357	5,578
Accumulated Other Comprehensive Income / (Loss)	-665	-779	-645	-698	-884	-794	-1,174	-719	-714	-709	-440
Noncontrolling Interest	193	202	197	202	208	217	197	190	182	180	0.00

This table displays calculated financial ratios and metrics derived from Aptiv's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-29.91%	12.98%	4.97%	12.04%	-0.54%	-8.99%	19.53%	11.98%	14.65%	-1.69%	3.47%
EBITDA Growth	-35.80%	11.99%	17.85%	10.78%	-6.72%	43.62%	-36.32%	7.88%	28.05%	12.62%	-21.86%
EBIT Growth	-35.94%	3.03%	20.78%	5.73%	-12.54%	64.19%	-49.95%	14.06%	34.16%	16.09%	-34.47%
NOPAT Growth	-30.05%	23.80%	-9.17%	2.80%	-5.89%	83.31%	-48.81%	4.88%	243.41%	-56.63%	-82.91%
Net Income Growth	6.60%	-13.62%	7.69%	-22.48%	-8.85%	80.57%	-66.58%	-3.12%	402.71%	-38.98%	-90.00%
EPS Growth	6.60%	-13.62%	10.24%	-20.55%	-4.23%	72.99%	-70.87%	1.03%	430.10%	-33.01%	-89.22%
Operating Cash Flow Growth	-20.23%	13.98%	-24.37%	10.90%	-0.25%	-12.99%	-13.52%	3.36%	50.12%	29.01%	-10.67%
Free Cash Flow Firm Growth	-158.37%	361.18%	-105.32%	-23.24%	751.80%	58.72%	-60.78%	-613.92%	129.89%	108.56%	-57.15%
Invested Capital Growth	51.32%	-22.33%	27.90%	22.90%	0.07%	3.88%	4.70%	58.73%	21.55%	-3.79%	-4.55%
Revenue Q/Q Growth	-25.97%	2.92%	37.50%	1.38%	-0.28%	4.95%	-0.50%	2.98%	1.41%	-0.06%	1.22%
EBITDA Q/Q Growth	-35.77%	9.18%	50.19%	-0.42%	-2.19%	6.37%	-15.67%	18.21%	0.16%	4.11%	-2.19%
EBIT Q/Q Growth	-36.31%	12.35%	49.20%	-3.72%	-1.60%	7.24%	-23.36%	33.15%	-2.87%	6.08%	-3.82%
NOPAT Q/Q Growth	-32.06%	39.67%	-3.46%	5.63%	-1.49%	4.84%	-11.96%	18.24%	23.35%	-22.89%	-39.58%
Net Income Q/Q Growth	-8.74%	6.85%	-1.99%	-1.77%	-34.69%	48.37%	-31.19%	62.53%	28.23%	-26.24%	-41.42%
EPS Q/Q Growth	-8.74%	6.85%	-2.32%	-1.23%	-35.51%	50.34%	-30.47%	71.93%	29.71%	-22.58%	-44.03%
Operating Cash Flow Q/Q Growth	-9.46%	-0.61%	-14.80%	25.33%	-3.22%	7.29%	-9.62%	26.43%	-14.01%	21.69%	-9.97%
Free Cash Flow Firm Q/Q Growth	-223.93%	972.06%	-120.80%	-115.39%	72.66%	-16.06%	-3.80%	-1,075.91%	134.26%	128.59%	-41.07%
Invested Capital Q/Q Growth	14.09%	-28.03%	-14.95%	4.30%	-2.47%	3.38%	1.70%	50.52%	5.32%	-6.13%	-3.32%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	20.00%	22.38%	20.29%	18.91%	18.43%	14.85%	15.60%	15.07%	17.15%	18.83%	19.11%
EBITDA Margin	13.59%	13.47%	15.12%	14.95%	14.02%	22.13%	11.79%	11.36%	12.68%	14.53%	10.95%
Operating Margin	11.37%	12.54%	10.99%	10.20%	8.89%	16.21%	7.61%	7.22%	7.78%	9.34%	5.80%
EBIT Margin	10.32%	9.41%	10.83%	10.22%	8.99%	16.21%	6.79%	6.91%	8.09%	9.55%	6.05%
Profit (Net Income) Margin	14.13%	10.80%	11.08%	7.67%	7.03%	13.94%	3.90%	3.37%	14.79%	9.18%	0.89%
Tax Burden Percent	153.96%	132.60%	113.78%	82.98%	89.61%	93.24%	66.92%	59.60%	221.84%	84.15%	19.70%
Interest Burden Percent	88.94%	86.58%	89.96%	90.44%	87.29%	92.26%	85.85%	81.89%	82.43%	114.23%	74.47%
Effective Tax Rate	16.15%	16.70%	17.77%	18.74%	11.72%	2.51%	11.10%	12.22%	-144.20%	10.37%	76.17%
Return on Invested Capital (ROIC)	20.72%	23.98%	21.86%	17.97%	15.33%	27.55%	13.52%	10.72%	27.08%	10.91%	1.95%
ROIC Less NNEP Spread (ROIC-NNEP)	44.23%	25.67%	33.92%	15.03%	11.98%	10.67%	100.69%	-23.48%	3.65%	14.31%	0.00%
Return on Net Nonoperating Assets (RNNOA)	32.71%	24.27%	23.62%	12.84%	10.95%	2.54%	-6.21%	-4.03%	1.25%	6.39%	0.00%
Return on Equity (ROE)	53.43%	48.25%	45.48%	30.81%	26.27%	30.09%	7.31%	6.68%	28.33%	17.30%	1.95%
Cash Return on Invested Capital (CROIC)	-20.12%	49.12%	-2.62%	-2.58%	15.26%	23.75%	8.93%	-34.68%	7.63%	14.77%	6.61%
Operating Return on Assets (OROA)	9.88%	9.52%	11.41%	11.97%	9.95%	13.67%	5.97%	6.06%	7.00%	7.86%	5.27%
Return on Assets (ROA)	13.53%	10.93%	11.68%	8.98%	7.78%	11.76%	3.43%	2.96%	12.81%	7.56%	0.77%
Return on Common Equity (ROCE)	44.26%	40.83%	41.28%	28.97%	24.89%	29.13%	7.13%	6.49%	27.55%	16.81%	1.89%
Return on Equity Simple (ROE_SIMPLE)	68.22%	55.23%	43.29%	32.00%	26.42%	23.05%	7.30%	6.70%	25.68%	20.58%	0.00%
Net Operating Profit after Tax (NOPAT)	1,036	1,282	1,164	1,197	1,126	2,065	1,057	1,109	3,807	1,651	282
NOPAT Margin	9.53%	10.44%	9.04%	8.29%	7.85%	15.80%	6.77%	6.34%	18.99%	8.38%	1.38%
Net Nonoperating Expense Percent (NNEP)	-23.51%	-1.69%	-12.06%	2.93%	3.35%	16.88%	-87.17%	34.20%	23.43%	-3.40%	1.94%
Return On Investment Capital (ROIC_SIMPLE)	15.36%	19.06%	15.19%	14.94%	13.45%	16.52%	8.17%	6.99%	20.68%	9.30%	1.63%
Cost of Revenue to Revenue	80.00%	77.62%	79.71%	81.09%	81.57%	85.15%	84.40%	84.93%	82.85%	81.17%	80.89%
SG&A Expenses to Revenue	7.39%	7.53%	7.39%	6.88%	7.49%	7.47%	6.88%	6.51%	7.16%	7.43%	8.20%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	8.63%	9.84%	9.30%	8.70%	9.54%	-1.36%	7.98%	7.84%	9.38%	9.48%	13.31%
Earnings before Interest and Taxes (EBIT)	1,121	1,155	1,395	1,475	1,290	2,118	1,060	1,209	1,622	1,883	1,234
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,476	1,653	1,948	2,158	2,013	2,891	1,841	1,986	2,543	2,864	2,234
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	10.11	7.33	8.36	4.63	6.33	4.45	5.35	2.86	2.20	1.62	1.79
Price to Tangible Book Value (P/TBV)	0.00	0.00	202.89	0.00	107.01	8.31	9.16	22.57	6.35	8.71	6.31
Price to Revenue (P/Rev)	2.09	1.43	2.14	1.11	1.68	2.69	2.86	1.44	1.27	0.72	0.81
Price to Earnings (P/E)	15.69	13.99	20.36	15.01	24.43	19.89	84.67	47.52	8.72	7.95	99.65
Dividend Yield	1.23%	1.79%	22.09%	29.69%	0.93%	0.68%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	6.38%	7.15%	4.91%	6.66%	4.09%	5.03%	1.18%	2.10%	11.46%	12.57%	1.00%
Enterprise Value to Invested Capital (EV/IC)	4.42	4.52	5.06	2.71	3.84	4.57	5.54	2.29	1.90	1.37	1.51
Enterprise Value to Revenue (EV/Rev)	2.45	1.72	2.35	1.38	1.96	2.67	2.83	1.66	1.46	1.03	1.05
Enterprise Value to EBITDA (EV/EBITDA)	18.03	12.77	15.54	9.22	14.01	12.08	24.05	14.66	11.51	7.07	9.58
Enterprise Value to EBIT (EV/EBIT)	23.73	18.28	21.70	13.49	21.86	16.48	41.76	24.08	18.04	10.76	17.34
Enterprise Value to NOPAT (EV/NOPAT)	25.69	16.47	26.00	16.62	25.04	16.91	41.88	26.26	7.68	12.27	75.85
Enterprise Value to Operating Cash Flow (EV/OCF)	15.62	10.88	20.62	12.22	17.37	24.71	36.23	23.05	15.43	8.28	9.79
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	8.04	0.00	0.00	25.15	19.62	63.42	0.00	27.29	9.06	22.34
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.47	1.43	1.18	1.18	1.09	0.54	0.51	0.75	0.56	0.96	0.84
Long-Term Debt to Equity	1.45	1.43	1.17	1.10	0.99	0.53	0.51	0.75	0.56	0.91	0.83
Financial Leverage	0.74	0.95	0.70	0.85	0.91	0.24	-0.06	0.17	0.34	0.45	0.56
Leverage Ratio	3.95	4.42	3.90	3.43	3.38	2.56	2.13	2.26	2.21	2.29	2.52
Compound Leverage Factor	3.51	3.82	3.50	3.10	2.95	2.36	1.83	1.85	1.82	2.61	1.88
Debt to Total Capital	59.46%	58.92%	54.12%	54.21%	52.11%	35.21%	33.80%	42.97%	36.01%	49.10%	45.57%
Short-Term Debt to Total Capital	0.77%	0.15%	0.22%	3.82%	4.69%	0.72%	0.06%	0.19%	0.05%	2.85%	0.46%
Long-Term Debt to Total Capital	58.69%	58.77%	53.90%	50.39%	47.41%	34.49%	33.74%	42.78%	35.96%	46.25%	45.10%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	7.17%	5.38%	2.84%	2.63%	2.29%	1.56%	1.65%	1.79%	1.60%	1.62%	1.67%
Common Equity to Total Capital	33.38%	35.70%	43.03%	43.16%	45.60%	63.23%	64.55%	55.24%	62.39%	49.28%	52.76%
Debt to EBITDA	2.72	2.40	2.13	2.01	2.17	1.52	2.37	3.45	2.62	3.06	3.56
Net Debt to EBITDA	2.29	1.91	1.26	1.70	1.90	-0.16	-0.31	1.81	1.41	2.01	2.09
Long-Term Debt to EBITDA	2.68	2.39	2.12	1.87	1.97	1.49	2.37	3.43	2.62	2.88	3.52
Debt to NOPAT	3.87	3.09	3.56	3.63	3.87	2.13	4.14	6.18	1.75	5.31	28.18
Net Debt to NOPAT	3.26	2.46	2.11	3.07	3.40	-0.22	-0.53	3.25	0.94	3.49	16.54
Long-Term Debt to NOPAT	3.82	3.08	3.55	3.37	3.53	2.09	4.13	6.15	1.75	5.00	27.90
Altman Z-Score	3.00	2.77	3.80	3.02	3.33	3.98	4.57	2.68	2.89	2.25	2.32
Noncontrolling Interest Sharing Ratio	17.16%	15.37%	9.24%	5.97%	5.25%	3.20%	2.45%	2.83%	2.77%	2.80%	3.13%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.30	1.31	1.59	1.29	1.31	1.85	2.01	1.60	1.72	1.53	1.74
Quick Ratio	0.84	0.69	1.14	0.83	0.74	1.39	1.41	1.02	1.08	0.94	1.06
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,005	2,626	-140	-172	1,121	1,780	698	-3,587	1,072	2,236	958
Operating Cash Flow to CapEx	338.57%	295.43%	210.32%	192.44%	211.73%	246.17%	202.99%	150.36%	210.20%	296.84%	341.41%
Free Cash Flow to Firm to Interest Expense	-8.11	16.94	-1.00	-1.22	6.84	10.85	4.65	-16.38	3.76	6.64	2.65
Operating Cash Flow to Interest Expense	13.73	12.52	10.49	11.55	9.90	8.62	8.15	5.77	6.65	7.26	6.05
Operating Cash Flow Less CapEx to Interest Expense	9.68	8.28	5.50	5.55	5.23	5.12	4.13	1.93	3.49	4.81	4.28
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.96	1.01	1.05	1.17	1.11	0.84	0.88	0.88	0.87	0.82	0.87
Accounts Receivable Turnover	4.22	5.03	5.64	5.86	5.68	4.86	5.58	5.63	5.75	5.79	6.05
Inventory Turnover	7.92	9.34	10.58	9.92	9.14	8.61	7.96	6.82	7.06	6.83	6.76
Fixed Asset Turnover	3.40	4.31	5.02	4.83	4.43	3.95	4.74	5.15	5.51	5.27	5.46
Accounts Payable Turnover	3.61	4.37	5.08	5.13	4.88	4.42	4.77	4.87	5.27	5.32	5.48
Days Sales Outstanding (DSO)	86.51	72.56	64.73	62.29	64.27	75.16	65.39	64.88	63.52	63.02	60.28
Days Inventory Outstanding (DIO)	46.07	39.08	34.51	36.79	39.94	42.37	45.84	53.49	51.69	53.43	53.99
Days Payable Outstanding (DPO)	101.19	83.54	71.92	71.11	74.75	82.57	76.48	74.98	69.22	68.67	66.66
Cash Conversion Cycle (CCC)	31.39	28.10	27.33	27.98	29.46	34.96	34.75	43.39	45.99	47.78	47.61
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	6,018	4,674	5,978	7,347	7,352	7,637	7,996	12,692	15,427	14,842	14,166
Invested Capital Turnover	2.17	2.30	2.42	2.17	1.95	1.74	2.00	1.69	1.43	1.30	1.41
Increase / (Decrease) in Invested Capital	2,041	-1,344	1,304	1,369	5.00	285	359	4,696	2,735	-585	-676
Enterprise Value (EV)	26,605	21,108	30,273	19,898	28,205	34,914	44,270	29,117	29,257	20,261	21,400
Market Capitalization	22,744	17,588	27,594	16,010	24,183	35,182	44,621	25,234	25,378	14,215	16,441
Book Value per Share	$8.03	$8.87	$12.41	$13.13	$14.96	$29.28	$30.86	$32.51	$40.83	$37.42	$42.61
Tangible Book Value per Share	($2.40)	($0.92)	$0.51	($1.69)	$0.89	$15.68	$18.01	$4.13	$14.13	$6.94	$12.07
Total Capital	6,741	6,726	7,666	8,014	8,375	12,501	12,932	15,946	18,510	17,849	17,451
Total Debt	4,008	3,963	4,149	4,344	4,364	4,401	4,371	6,852	6,666	8,764	7,952
Total Long-Term Debt	3,956	3,953	4,132	4,038	3,971	4,311	4,363	6,821	6,657	8,255	7,871
Net Debt	3,378	3,158	2,461	3,677	3,830	-463	-565	3,598	3,583	5,757	4,667
Capital Expenditures (CapEx)	503	657	698	846	767	574	602	840	902	824	640
Debt-free, Cash-free Net Working Capital (DFCFNWC)	710	543	521	821	1,230	656	1,098	1,419	1,808	1,630	1,935
Debt-free Net Working Capital (DFNWC)	1,246	1,281	2,118	1,389	1,658	3,509	4,237	2,950	3,448	3,204	3,789
Net Working Capital (NWC)	1,194	1,271	2,101	1,083	1,265	3,419	4,229	2,919	3,439	2,695	3,708
Net Nonoperating Expense (NNE)	-499	-44	-264	90	117	243	448	519	841	-159	101
Net Nonoperating Obligations (NNO)	3,285	1,911	2,461	3,677	3,341	-463	-565	3,598	3,583	5,757	4,667
Total Depreciation and Amortization (D&A)	355	498	553	683	723	773	781	777	921	981	1,000
Debt-free, Cash-free Net Working Capital to Revenue	6.54%	4.42%	4.04%	5.69%	8.57%	5.02%	7.03%	8.11%	9.02%	8.27%	9.49%
Debt-free Net Working Capital to Revenue	11.47%	10.44%	16.44%	9.62%	11.55%	26.86%	27.13%	16.87%	17.20%	16.25%	18.58%
Net Working Capital to Revenue	10.99%	10.36%	16.31%	7.50%	8.81%	26.17%	27.08%	16.69%	17.15%	13.67%	18.18%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.00	$3.85	$6.72	$1.95	$1.96	$10.50	$6.97	$0.75
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	0.00	0.00	256.81M	263.43M	270.46M	270.90M	276.92M	256.38M	220M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$3.85	$6.66	$1.94	$1.96	$10.39	$6.96	$0.75
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	0.00	0.00	257.39M	270.70M	271.22M	271.18M	282.88M	256.66M	220.75M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	0.00	255.29M	270.03M	270.51M	270.95M	279.04M	229.45M	212.75M
Normalized Net Operating Profit after Tax (NOPAT)	1,090	1,421	1,270	1,286	1,257	2,197	1,078	1,183	1,239	1,824	1,412
Normalized NOPAT Margin	10.03%	11.58%	9.86%	8.91%	8.76%	16.82%	6.90%	6.77%	6.18%	9.25%	6.92%
Pre Tax Income Margin	9.18%	8.15%	9.74%	9.24%	7.84%	14.95%	5.83%	5.66%	6.67%	10.91%	4.51%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	9.04	7.45	9.96	10.46	7.87	12.91	7.07	5.52	5.69	5.59	3.42
NOPAT to Interest Expense	8.35	8.27	8.32	8.49	6.87	12.59	7.05	5.06	13.36	4.90	0.78
EBIT Less CapEx to Interest Expense	4.98	3.21	4.98	4.46	3.19	9.41	3.05	1.68	2.53	3.14	1.65
NOPAT Less CapEx to Interest Expense	4.29	4.03	3.33	2.49	2.19	9.09	3.03	1.23	10.19	2.45	-0.99
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	22.74%	27.07%	24.37%	23.76%	23.49%	5.38%	10.34%	12.20%	1.15%	0.00%	3.31%
Augmented Payout Ratio	98.24%	74.89%	51.19%	68.83%	65.11%	8.51%	10.34%	12.20%	14.57%	226.74%	222.65%

This table displays calculated financial ratios and metrics derived from Aptiv's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q2 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	6/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	211,620,527.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	211,620,527.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	1.17
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	10.84%	6.01%	1.72%	-2.87%	-5.08%	-0.24%	-1.55%	3.11%	7.38%	5.01%	2.34%
EBITDA Growth	2.49%	0.64%	17.88%	8.18%	7.71%	17.94%	3.90%	7.13%	-87.00%	-6.10%	-0.63%
EBIT Growth	-3.67%	-11.16%	25.07%	7.13%	7.63%	28.27%	3.23%	10.42%	-130.12%	-10.00%	25.00%
NOPAT Growth	373.11%	175.83%	8.82%	11.84%	-75.86%	-65.47%	-100.38%	4.44%	-126.43%	-51.44%	10.06%
Net Income Growth	434.97%	245.49%	36.59%	283.33%	-77.52%	-70.08%	-104.91%	-57.90%	-195.65%	-46.55%	-37.78%
EPS Growth	448.57%	273.56%	46.30%	313.10%	-74.31%	-62.46%	-106.33%	-48.13%	-210.14%	-48.36%	-35.00%
Operating Cash Flow Growth	70.71%	-33.12%	2,811.11%	20.19%	-33.11%	69.87%	11.89%	-20.68%	17.03%	-22.83%	0.00%
Free Cash Flow Firm Growth	-2,516.52%	62.58%	54.43%	65.98%	83.72%	160.83%	135.95%	133.93%	248.17%	-11.27%	752.25%
Invested Capital Growth	73.72%	21.55%	17.70%	14.72%	7.94%	-3.79%	-4.66%	-0.62%	-7.33%	-4.55%	-20.09%
Revenue Q/Q Growth	-1.65%	-3.81%	-0.37%	3.06%	-3.90%	1.09%	-1.67%	7.94%	0.08%	-1.13%	0.00%
EBITDA Q/Q Growth	8.02%	-10.00%	5.71%	5.26%	7.56%	-1.46%	-6.86%	8.53%	-86.95%	607.14%	0.00%
EBIT Q/Q Growth	12.11%	-19.07%	13.61%	3.92%	12.64%	-3.54%	-8.57%	11.16%	-130.72%	388.24%	0.00%
NOPAT Q/Q Growth	412.32%	-41.08%	-70.59%	25.98%	10.58%	-15.71%	-100.32%	34,785.55%	-127.99%	254.85%	0.00%
Net Income Q/Q Growth	565.45%	-43.86%	-75.63%	320.98%	-60.98%	-25.27%	-104.00%	3,709.09%	-188.67%	141.76%	0.00%
EPS Q/Q Growth	585.71%	-43.58%	-75.69%	339.24%	-57.35%	-17.57%	-104.10%	3,700.00%	-190.56%	138.65%	0.00%
Operating Cash Flow Q/Q Growth	39.44%	-16.35%	-60.90%	163.52%	-22.40%	112.42%	-74.25%	86.81%	14.51%	40.07%	0.00%
Free Cash Flow Firm Q/Q Growth	7.08%	62.67%	-27.09%	22.83%	55.52%	239.47%	-24.90%	-27.16%	94.20%	-16.48%	0.00%
Invested Capital Q/Q Growth	8.26%	5.32%	2.19%	-1.54%	1.86%	-6.13%	1.27%	2.63%	-5.02%	-3.32%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	17.46%	18.74%	17.91%	19.16%	18.60%	19.60%	19.07%	19.14%	19.53%	18.69%	23.67%
EBITDA Margin	13.69%	12.81%	13.59%	13.88%	15.53%	15.14%	14.34%	14.42%	1.88%	13.45%	14.57%
Operating Margin	8.72%	7.22%	8.55%	8.73%	10.36%	9.76%	9.29%	9.33%	-3.36%	8.25%	11.21%
EBIT Margin	9.23%	7.77%	8.86%	8.93%	10.47%	9.99%	9.29%	9.56%	-2.94%	8.56%	12.98%
Profit (Net Income) Margin	32.01%	18.68%	4.57%	18.67%	7.58%	5.60%	-0.23%	7.62%	-6.75%	2.85%	7.54%
Tax Burden Percent	412.34%	295.50%	60.70%	91.73%	90.42%	79.25%	-3.10%	87.64%	144.86%	41.53%	37.25%
Interest Burden Percent	84.11%	81.41%	85.02%	227.94%	80.12%	70.82%	79.24%	90.96%	158.82%	80.27%	156.00%
Effective Tax Rate	-330.48%	-218.65%	20.60%	4.96%	7.86%	18.44%	100.28%	9.93%	0.00%	55.37%	7.84%
Return on Invested Capital (ROIC)	64.32%	32.80%	9.37%	11.42%	12.37%	10.37%	-0.03%	10.75%	-3.11%	5.18%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	48.72%	26.89%	6.81%	24.91%	10.49%	7.89%	-0.23%	9.87%	-7.03%	4.36%	0.00%
Return on Net Nonoperating Assets (RNNOA)	9.08%	9.22%	2.79%	9.08%	5.27%	3.52%	-0.11%	4.18%	-4.39%	2.44%	0.00%
Return on Equity (ROE)	73.40%	42.02%	12.16%	20.50%	17.64%	13.89%	-0.14%	14.93%	-7.50%	7.62%	0.00%
Cash Return on Invested Capital (CROIC)	-27.12%	7.63%	9.70%	7.85%	6.42%	14.77%	14.06%	9.06%	10.68%	6.61%	0.00%
Operating Return on Assets (OROA)	8.36%	6.72%	7.86%	7.62%	8.52%	8.22%	7.80%	7.77%	-2.45%	7.45%	0.00%
Return on Assets (ROA)	28.98%	16.18%	4.06%	15.93%	6.17%	4.61%	-0.19%	6.20%	-5.64%	2.48%	0.00%
Return on Common Equity (ROCE)	71.59%	40.85%	11.82%	19.93%	17.11%	13.50%	-0.14%	14.52%	-7.26%	7.38%	0.00%
Return on Equity Simple (ROE_SIMPLE)	21.46%	0.00%	27.21%	32.47%	27.63%	0.00%	17.58%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	1,920	1,131	333	419	463	391	-1.26	438	-123	190	338
NOPAT Margin	37.54%	23.00%	6.79%	8.30%	9.55%	7.96%	-0.03%	8.40%	-2.35%	3.68%	10.33%
Net Nonoperating Expense Percent (NNEP)	15.61%	5.91%	2.57%	-13.50%	1.87%	2.48%	0.19%	0.88%	3.92%	0.82%	2.02%
Return On Investment Capital (ROIC_SIMPLE)	10.75%	6.14%	1.85%	2.20%	2.43%	2.20%	-0.01%	2.42%	-0.70%	1.09%	2.36%
Cost of Revenue to Revenue	82.54%	81.26%	82.09%	80.84%	81.40%	80.40%	80.93%	80.86%	80.47%	81.31%	76.33%
SG&A Expenses to Revenue	7.04%	7.75%	7.47%	8.02%	6.82%	7.40%	7.96%	7.80%	8.31%	8.73%	10.14%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	8.74%	11.53%	9.37%	10.43%	8.24%	9.84%	9.78%	9.81%	22.89%	10.44%	12.46%
Earnings before Interest and Taxes (EBIT)	472	382	434	451	508	490	448	498	-153	441	425
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	700	630	666	701	754	743	692	751	98	693	477
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.59	2.20	0.00	1.67	2.15	1.62	1.52	1.53	2.02	1.79	1.48
Price to Tangible Book Value (P/TBV)	8.50	6.35	0.00	4.64	12.96	8.71	7.72	6.36	7.13	6.31	4.42
Price to Revenue (P/Rev)	1.41	1.27	0.00	0.96	0.97	0.72	0.70	0.75	0.93	0.81	0.00
Price to Earnings (P/E)	12.46	8.72	0.00	5.19	7.90	7.95	8.76	14.66	63.64	99.65	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	15.35%
Earnings Yield	8.02%	11.46%	0.00%	19.26%	12.67%	12.57%	11.41%	6.82%	1.57%	1.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.17	1.90	0.00	1.50	1.65	1.37	1.31	1.33	1.65	1.51	1.34
Enterprise Value to Revenue (EV/Rev)	1.61	1.46	0.00	1.16	1.32	1.03	1.00	1.04	1.20	1.05	0.00
Enterprise Value to EBITDA (EV/EBITDA)	12.51	11.51	0.00	8.61	9.48	7.07	6.82	7.00	10.57	9.58	0.00
Enterprise Value to EBIT (EV/EBIT)	19.01	18.04	0.00	13.35	14.69	10.76	10.40	10.59	18.82	17.34	0.00
Enterprise Value to NOPAT (EV/NOPAT)	10.29	7.68	0.00	7.41	12.17	12.27	13.79	15.76	51.71	75.85	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	14.40	15.43	0.00	10.29	12.97	8.28	7.97	8.79	9.95	9.79	12.26
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	27.29	0.00	20.35	26.65	9.06	9.11	14.68	14.85	22.34	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.62	0.56	0.58	0.63	1.08	0.96	0.90	0.82	0.84	0.84	0.64
Long-Term Debt to Equity	0.62	0.56	0.45	0.50	0.95	0.91	0.87	0.82	0.84	0.83	0.64
Financial Leverage	0.19	0.34	0.41	0.36	0.50	0.45	0.49	0.42	0.62	0.56	0.48
Leverage Ratio	2.25	2.21	2.19	2.20	2.39	2.29	2.26	2.24	2.57	2.52	2.24
Compound Leverage Factor	1.89	1.80	1.86	5.02	1.92	1.62	1.79	2.04	4.09	2.02	3.49
Debt to Total Capital	38.33%	36.01%	36.80%	38.65%	51.99%	49.10%	47.31%	45.15%	45.65%	45.57%	39.00%
Short-Term Debt to Total Capital	0.24%	0.05%	8.23%	7.69%	6.56%	2.85%	1.37%	0.18%	0.10%	0.46%	0.16%
Long-Term Debt to Total Capital	38.09%	35.96%	28.57%	30.97%	45.43%	46.25%	45.94%	44.98%	45.56%	45.10%	38.83%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.64%	1.60%	1.65%	1.58%	1.65%	1.62%	1.67%	1.57%	1.60%	1.67%	0.00%
Common Equity to Total Capital	60.03%	62.39%	61.54%	59.77%	46.36%	49.28%	51.02%	53.28%	52.74%	52.76%	61.01%
Debt to EBITDA	2.71	2.62	2.52	2.75	3.62	3.06	2.88	2.79	3.52	3.56	0.00
Net Debt to EBITDA	1.41	1.41	1.64	1.39	2.40	2.01	2.00	1.85	2.23	2.09	0.00
Long-Term Debt to EBITDA	2.69	2.62	1.95	2.20	3.16	2.88	2.79	2.78	3.51	3.52	0.00
Debt to NOPAT	2.23	1.75	1.76	2.37	4.65	5.31	5.81	6.29	17.20	28.18	0.00
Net Debt to NOPAT	1.16	0.94	1.15	1.20	3.09	3.49	4.04	4.17	10.90	16.54	0.00
Long-Term Debt to NOPAT	2.22	1.75	1.36	1.90	4.07	5.00	5.64	6.26	17.17	27.90	0.00
Altman Z-Score	2.86	2.72	0.00	2.37	2.12	2.06	2.06	2.11	2.22	2.20	0.00
Noncontrolling Interest Sharing Ratio	2.47%	2.77%	2.84%	2.79%	3.01%	2.80%	2.86%	2.70%	3.19%	3.13%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.81	1.72	1.29	1.49	1.50	1.53	1.61	1.76	1.79	1.74	2.02
Quick Ratio	1.16	1.08	0.77	0.97	0.95	0.94	0.97	1.09	1.10	1.06	1.07
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-4,296	-1,604	-2,038	-1,573	-700	976	733	534	1,037	866	3,437
Operating Cash Flow to CapEx	351.89%	308.91%	92.08%	284.51%	290.12%	650.31%	139.29%	344.59%	408.39%	534.64%	0.00%
Free Cash Flow to Firm to Interest Expense	-57.28	-22.59	-31.36	-24.58	-6.93	9.12	7.88	5.87	11.52	9.95	55.44
Operating Cash Flow to Interest Expense	9.95	8.79	3.75	10.05	4.94	9.91	2.94	5.60	6.49	9.40	0.00
Operating Cash Flow Less CapEx to Interest Expense	7.12	5.94	-0.32	6.52	3.24	8.38	0.83	3.98	4.90	7.64	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.91	0.87	0.89	0.85	0.81	0.82	0.84	0.81	0.84	0.87	0.00
Accounts Receivable Turnover	5.64	5.75	5.58	5.46	5.40	5.79	5.45	5.42	5.47	6.05	0.00
Inventory Turnover	6.94	7.06	6.83	6.87	6.44	6.83	6.62	6.61	6.32	6.76	0.00
Fixed Asset Turnover	5.87	5.51	5.51	5.46	5.35	5.27	5.28	5.29	5.36	5.46	0.00
Accounts Payable Turnover	5.64	5.27	5.63	5.49	5.31	5.32	5.49	5.38	5.31	5.48	0.00
Days Sales Outstanding (DSO)	64.73	63.52	65.41	66.85	67.54	63.02	66.92	67.39	66.71	60.28	0.00
Days Inventory Outstanding (DIO)	52.59	51.69	53.46	53.10	56.63	53.43	55.15	55.22	57.79	53.99	0.00
Days Payable Outstanding (DPO)	64.72	69.22	64.83	66.44	68.72	68.67	66.44	67.86	68.70	66.66	0.00
Cash Conversion Cycle (CCC)	52.60	45.99	54.04	53.52	55.46	47.78	55.63	54.75	55.79	47.61	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	14,648	15,427	15,765	15,523	15,811	14,842	15,031	15,427	14,652	14,166	12,328
Invested Capital Turnover	1.71	1.43	1.38	1.38	1.30	1.30	1.28	1.28	1.32	1.41	0.00
Increase / (Decrease) in Invested Capital	6,216	2,735	2,371	1,992	1,163	-585	-734	-96	-1,159	-676	-3,099
Enterprise Value (EV)	31,754	29,257	0.00	23,215	26,066	20,261	19,722	20,591	24,145	21,400	16,564
Market Capitalization	27,884	25,378	0.00	19,159	19,137	14,215	13,652	14,854	18,775	16,441	12,989
Book Value per Share	$38.11	$40.83	$40.41	$42.15	$33.42	$37.42	$39.05	$44.50	$42.62	$42.61	$41.36
Tangible Book Value per Share	$11.60	$14.13	$13.39	$15.17	$5.56	$6.94	$7.71	$10.73	$12.10	$12.07	$13.90
Total Capital	17,954	18,510	18,069	19,186	19,159	17,849	17,563	18,187	17,598	17,451	14,348
Total Debt	6,881	6,666	6,650	7,416	9,961	8,764	8,309	8,212	8,034	7,952	5,595
Total Long-Term Debt	6,838	6,657	5,163	5,941	8,704	8,255	8,068	8,180	8,017	7,871	5,572
Net Debt	3,575	3,583	4,346	3,753	6,613	5,757	5,777	5,452	5,088	4,667	3,575
Capital Expenditures (CapEx)	212	202	265	226	172	163	196	148	143	153	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2,029	1,808	2,281	2,239	2,296	1,630	2,084	2,205	2,249	1,935	2,286
Debt-free Net Working Capital (DFNWC)	3,837	3,448	3,222	4,396	4,141	3,204	3,185	3,654	3,892	3,789	3,051
Net Working Capital (NWC)	3,794	3,439	1,735	2,921	2,884	2,695	2,944	3,622	3,875	3,708	3,028
Net Nonoperating Expense (NNE)	283	212	109	-524	95	116	9.74	41	230	43	91
Net Nonoperating Obligations (NNO)	3,575	3,583	4,346	3,753	6,613	5,757	5,777	5,452	5,088	4,667	3,575
Total Depreciation and Amortization (D&A)	228	248	232	250	246	253	244	253	251	252	52
Debt-free, Cash-free Net Working Capital to Revenue	10.26%	9.02%	11.33%	11.20%	11.64%	8.27%	10.61%	11.14%	11.16%	9.49%	0.00%
Debt-free Net Working Capital to Revenue	19.41%	17.20%	16.00%	22.00%	20.99%	16.25%	16.22%	18.46%	19.31%	18.58%	0.00%
Net Working Capital to Revenue	19.19%	17.15%	8.62%	14.62%	14.62%	13.67%	14.99%	18.30%	19.23%	18.18%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$5.76	$3.36	$0.79	$3.47	$1.48	$1.23	($0.05)	$1.80	($1.63)	$0.63	$1.17
Adjusted Weighted Average Basic Shares Outstanding	282.84M	276.92M	275.19M	270.19M	245.48M	256.38M	230.16M	217.73M	217.41M	220M	211.56M
Adjusted Diluted Earnings per Share	$5.76	$3.25	$0.79	$3.47	$1.48	$1.22	($0.05)	$1.80	($1.63)	$0.63	$1.17
Adjusted Weighted Average Diluted Shares Outstanding	283.01M	282.88M	275.31M	270.43M	245.78M	256.66M	230.16M	218.11M	217.41M	220.75M	212.10M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	282.86M	279.04M	272.06M	265.76M	235.04M	229.45M	217.73M	217.76M	216.08M	212.75M	207.63M
Normalized Net Operating Profit after Tax (NOPAT)	332	340	364	486	478	446	340	485	373	323	360
Normalized NOPAT Margin	6.49%	6.90%	7.42%	9.61%	9.85%	9.09%	7.04%	9.30%	7.16%	6.26%	11.01%
Pre Tax Income Margin	7.76%	6.32%	7.53%	20.35%	8.38%	7.07%	7.36%	8.70%	-4.66%	6.87%	20.25%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	6.29	5.38	6.68	7.05	5.03	4.58	4.82	5.47	-1.70	5.07	6.85
NOPAT to Interest Expense	25.60	15.93	5.12	6.55	4.59	3.65	-0.01	4.81	-1.36	2.18	5.46
EBIT Less CapEx to Interest Expense	3.47	2.54	2.60	3.52	3.33	3.06	2.71	3.85	-3.29	3.31	0.00
NOPAT Less CapEx to Interest Expense	22.77	13.09	1.04	3.02	2.89	2.13	-2.12	3.18	-2.95	0.42	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	2.12%	1.15%	0.59%	0.05%	0.08%	0.00%	0.00%	0.00%	1.94%	3.31%	0.00%
Augmented Payout Ratio	6.36%	14.57%	31.33%	35.78%	179.54%	226.74%	222.48%	298.74%	33.01%	222.65%	0.00%

Financials Breakdown Chart

Key Financial Trends

Aptiv’s latest results show a clear rebound from the weak middle of 2025, but the full picture is still mixed. The company ended Q4 2025 with higher revenue, a return to solid profitability, and strong operating cash flow. At the same time, the balance sheet still carries meaningful debt, and 2025 overall was more volatile than the latest quarter suggests.

Q4 2025 revenue improved year over year. Revenue rose to $5.15 billion from $4.91 billion in Q4 2024.
Q4 2025 profits recovered sharply from the prior quarter. Net income was $147 million versus a $352 million loss in Q3 2025.
Operating cash flow remained strong. Aptiv generated $818 million of cash from operations in Q4 2025, up from $584 million in Q3 2025.
Gross profit margin improved modestly. Q4 2025 gross profit was $963 million, or about 18.7% of revenue, slightly better than Q3 2025.
Cash balance strengthened in Q4 2025. Cash and equivalents rose to $1.64 billion from $1.45 billion in Q2 2025 and $1.57 billion at year-end 2024.
Equity increased during 2025. Total common equity rose to $9.28 billion in Q3 2025 from $8.80 billion at year-end 2024.
Revenue growth over the last year has been uneven. Q4 2025 revenue was up from Q4 2024, but quarterly sales across 2025 were relatively flat around the $5.1 billion to $5.2 billion range.
Aptiv continues to spend on capital investments. Q4 2025 capex was $167 million, which supports operations but also uses cash.
Share repurchases continue. The company repurchased $301 million of common equity in Q4 2025, which can support EPS but also reduces cash.
Q3 2025 was a setback. The company posted a $352 million loss in Q3 2025, driven by elevated operating expenses and a large impairment charge.
Operating expenses can be volatile. Q3 2025 included a $648 million impairment charge and $60 million of restructuring costs, highlighting ongoing restructuring pressure.
Debt remains significant. Long-term debt was $7.61 billion at Q3 2025, with additional short-term debt and lease obligations on the balance sheet.
Balance sheet leverage has risen versus earlier periods. Total liabilities were $13.93 billion at Q3 2025, compared with $12.58 billion at year-end 2024.
AOCI remains deeply negative. Accumulated other comprehensive income/loss was -$709 million in Q3 2025, reflecting persistent balance-sheet headwinds.

Bottom line: Aptiv’s Q4 2025 results show improving operational momentum and healthy cash generation after a difficult Q3, but investors should keep an eye on debt levels, restructuring costs, and whether the earnings recovery can hold up across 2026.

08/15/26 11:46 PM ETAI Generated. May Contain Errors.

Aptiv Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Aptiv's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Over the last 10 years, Aptiv's net income changed from $1.54 billion in 2015 to $181 million in 2025, a change of -88.2%. View Aptiv's forecast to see where analysts expect Aptiv to go next.

Aptiv's total operating income in 2025 was $1.18 billion, based on the following breakdown:

Total Gross Profit: $3.90 billion
Total Operating Expenses: $2.71 billion

Over the last 10 years, Aptiv's total revenue changed from $10.86 billion in 2015 to $20.40 billion in 2025, a change of 87.8%.

Aptiv's total liabilities were at $13.91 billion at the end of 2025, a 3.2% decrease from 2024, and a 50.6% increase since 2015.

In the past 10 years, Aptiv's cash and equivalents has ranged from $412 million in 2019 to $3.14 billion in 2021, and is currently $1.58 billion as of their latest financial filing in 2025.

Over the last 10 years, Aptiv's book value per share changed from 8.03 in 2015 to 42.61 in 2025, a change of 430.4%.

Related Companies

Financial statements for NYSE:APTV last updated on 8/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aptiv (APTV) Financials

Financials Breakdown Chart

Key Financial Trends

Aptiv Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aptiv (APTV) Financials

Annual Income Statements for Aptiv

Quarterly Income Statements for Aptiv

Annual Cash Flow Statements for Aptiv

Quarterly Cash Flow Statements for Aptiv

Annual Balance Sheets for Aptiv

Quarterly Balance Sheets for Aptiv

Annual Metrics And Ratios for Aptiv

Quarterly Metrics And Ratios for Aptiv

Financials Breakdown Chart

Key Financial Trends

Aptiv Financials - Frequently Asked Questions

When does Aptiv's fiscal year end?

How has Aptiv's net income changed over the last 10 years?

What is Aptiv's operating income?

How has Aptiv's revenue changed over the last 10 years?

How much debt does Aptiv have?

How much cash does Aptiv have?

How has Aptiv's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools